Report found that 885 drugs were potentially misclassified in Medicaid drug rebate program
"We are deeply concerned about these potentially longstanding weaknesses in the agency's oversight of the accuracy of drug classifications for the purposes of the Medicaid drug rebate program," wrote the bipartisan group of Senators to the
A recent report from the internal watchdog that oversees the Medicaid program found that 885 drugs were potentially misclassified in the Medicaid drug rebate program, and the top 10 potentially misclassified drugs potentially cost Medicaid
McCaskill has made tackling rising healthcare and prescription drug costs a top priority in the
McCaskill recently introduced legislation to end taxpayer subsidies pharmaceutical companies receive for the billions of dollars they spend on prescription drug advertising each year, which currently is fully tax-deductible. Additionally, McCaskill's bipartisan legislation to increase competition for generic drugs and help lower prescription costs was signed into law by
Full text of letter HERE https://www.mccaskill.senate.gov/download/letter-to-cms-on-medicaid-drug-rebates.
Visit mccaskill.senate.gov/healthcare to learn more about McCaskill's fight to improve healthcare for Missourians.
Read this original document at: https://www.mccaskill.senate.gov/media-center/news-releases/following-report-of-13-billion-in-potential-losses-from-medicaid-drug-rebate-programmccaskill-calls-for-action-answers
Florida Man Pleads Guilty In Staged Accident Scheme
After Canandaigua VA Was Targeted For Closure in 2003, Schumer Led the Charge to Secure Over $161 Million in Funding from the VA To Modernize the Canandaigua Campus
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News